Why an HIV patient advocacy group is suing the Trump administration over a Biden administration legal settlement with Gilead ...

This was the stock's second consecutive day of gains.

Shares of Gilead Sciences Inc. GILD slid 2.15% to $112.29 Thursday, on what proved to be an all-around rough trading session ...

Washington has long failed to come up with a solution for rising drug prices that addresses the concerns of drugmakers, ...

Sydney Sweeney’s performance just takes it to that next level. Eden is Gilead’s poster child straight out of the nightmare handbook. She shows up in The Handmaid’s Tale Season 2, Episode 5 (“Seeds”), ...

Never mistake a woman’s meekness for weakness,” Serena Joy says in The Handmaid’s Tale. Gilead is a scary place. There is ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the top cheap pharmaceutical stocks to buy now. Morgan Stanley analyst Terence ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

On July 16, 49 attorneys general (AGs) announced that they joined a $202 million settlement with Gilead Sciences, Inc. (Gilead). Previously ...

Get a deeper insight into the potential performance of Gilead (GILD) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of ...

Among its other ratings, Gilead's Accumulation/Distribution Rating of B shows moderate buying by institutional investors over ...

The largest group of Black physicians, thought leaders, and celebrities were in one room to have a needed discussion about HIV.